Diagnostics & Research
The Diagnostics & Research industry has a total of 44 stocks, with a combined market cap of $866.07 billion, total revenue of $172.71 billion and a weighted average PE ratio of 47.88.
Market Cap
866.07B
Revenue
172.71B
Profits
18.09B
PE Ratio
47.88
Profit Margin
10.47%
Dividend Yield
0.20%
44 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | TMO | Thermo Fisher Scientific Inc. | 240.87B | -1.04% | 4,582,399 | 46.34B |
| 2 | DHR | Danaher Corporation | 148.90B | -0.32% | 8,834,998 | 25.11B |
| 3 | NTRA | Natera, Inc. | 53.25B | 0.84% | 3,717,071 | 2.71B |
| 4 | A | Agilent Technologies, Inc. | 44.11B | 0.08% | 4,852,144 | 7.37B |
| 5 | IQV | IQVIA Holdings Inc. | 43.85B | -1.12% | 5,595,940 | 16.98B |
| 6 | WAT | Waters Corporation | 41.42B | -1.88% | 1,035,736 | 4.64B |
| 7 | IDXX | IDEXX Laboratories, Inc. | 40.31B | 1.02% | 1,124,648 | 4.55B |
| 8 | ILMN | Illumina, Inc. | 36.18B | -2.27% | 32,588,764 | 4.49B |
| 9 | MTD | Mettler-Toledo International Inc. | 27.90B | -1.28% | 544,487 | 4.13B |
| 10 | DGX | Quest Diagnostics Incorporated | 27.20B | -0.40% | 1,925,630 | 11.56B |
| 11 | LH | Labcorp Holdings Inc. | 26.01B | -0.63% | 1,738,507 | 14.35B |
| 12 | GH | Guardant Health, Inc. | 24.07B | -2.03% | 3,080,734 | 1.18B |
| 13 | MEDP | Medpace Holdings, Inc. | 17.09B | -0.46% | 522,189 | 2.78B |
| 14 | RVTY | Revvity, Inc. | 16.01B | -2.24% | 3,321,765 | 2.91B |
| 15 | CRL | Charles River Laboratories International, Inc. | 13.27B | -1.28% | 1,481,163 | 4.00B |
| 16 | ICLR | ICON Public Limited Company | 12.66B | -3.28% | 1,122,535 | 8.29B |
| 17 | QGEN | Qiagen N.V. | 8.96B | -2.37% | 1,748,675 | 2.10B |
| 18 | RDNT | RadNet, Inc. | 5.98B | -2.29% | 1,280,771 | 2.27B |
| 19 | SHC | Sotera Health Company | 5.35B | -1.16% | 6,366,642 | 1.22B |
| 20 | BLLN | BillionToOne, Inc. | 5.00B | -4.29% | 1,943,435 | 397.41M |
| 21 | ADPT | Adaptive Biotechnologies Corporation | 4.57B | 0.21% | 2,985,502 | 308.08M |
| 22 | GRAL | GRAIL, Inc. | 3.61B | 1.03% | 3,003,701 | 165.26M |
| 23 | VCYT | Veracyte, Inc. | 3.20B | -1.91% | 2,667,720 | 561.90M |
| 24 | WGS | GeneDx Holdings Corp. | 3.02B | -3.67% | 786,125 | 454.43M |
| 25 | CDNA | CareDx, Inc. | 2.78B | -0.83% | 1,383,987 | 458.09M |
| 26 | NEO | NeoGenomics, Inc. | 2.56B | 0.10% | 4,400,261 | 766.30M |
| 27 | FRNM | Freenome, Inc. | 1.84B | 5.03% | 6,047,297 | 35.41M |
| 28 | PSNL | Personalis, Inc. | 1.75B | 1.05% | 3,160,496 | 69.67M |
| 29 | OPK | OPKO Health, Inc. | 1.25B | 3.09% | 5,344,172 | 587.90M |
| 30 | CSTL | Castle Biosciences, Inc. | 1.08B | -3.92% | 530,191 | 357.28M |
| 31 | FLGT | Fulgent Genetics, Inc. | 596.81M | -0.73% | 669,174 | 323.93M |
| 32 | MYGN | Myriad Genetics, Inc. | 372.08M | -6.04% | 3,509,957 | 806.60M |
| 33 | BDSX | Biodesix, Inc. | 308.09M | 1.35% | 100,849 | 102.94M |
| 34 | XGN | Exagen Inc. | 203.74M | 6.86% | 351,725 | 71.12M |
| 35 | BNR | Burning Rock Biotech Limited | 150.13M | 5.29% | 23,990 | 73.70M |
| 36 | IMDX | Insight Molecular Diagnostics Inc. | 130.90M | 2.03% | 317,921 | 1.67M |
| 37 | QUCY | Quantum Cyber N.V. | 116.01M | 1.47% | 296,890 | 537.08K |
| 38 | MDXH | MDxHealth SA | 60.11M | -6.21% | 276,373 | 114.02M |
| 39 | PRPO | Precipio, Inc. | 47.37M | 0.08% | 189,155 | 27.20M |
| 40 | ADVB | Advanced Biomed Inc. | 10.80M | -10.66% | 59,543 | - |
| 41 | NDRA | ENDRA Life Sciences Inc. | 8.25M | 1.48% | 17,835 | - |
| 42 | XWEL | XWELL, Inc. | 7.73M | -0.55% | 42,387 | 28.28M |
| 43 | BIAF | bioAffinity Technologies, Inc. | 5.09M | 7.77% | 10,395,950 | 5.90M |
| 44 | ISPC | iSpecimen Inc. | 3.35M | -1.48% | 55,402 | 466.30K |